Trial reportBMC anesthesiology2025
Parascapular sub-iliocostalis plane block for postoperative analgesia in patients with multiple rib fractures: a randomized controlled trial.
Trial report in BMC anesthesiology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
3 citing papers in PubMed.
- Fascia iliaca compartment block for surgical analgesia in children with osteogenesis imperfecta: A retrospective cohort study.PloS one · 2026Article
- The Analgesic Effect of Infraspinatus Teres Minor Block in Scapular Fracture Surgery: A Randomized Controlled Trial.Journal of pain research · 2026Article
- Contemporary and Future Perspectives on Thoracic Trauma Care: Surgical Stabilization, Multidisciplinary Approaches, and the Role of Artificial Intelligence.Journal of clinical medicine · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
Abstract
backgroundPatients with multiple rib fractures (MRFs) often experience severe postoperative pain. The parascapular sub-iliocostalis plane (PSIP) block holds promise as an effective method for analgesia, warranting further investigation and validation.
methodsIn this double-masked randomized trial, eligible MRF patients underwent surgery and were allocated to receive either preoperative PSIP block (intervention) or standard care (control). Postoperative outcomes including pain trajectories (serial VAS assessments), analgesic consumption, hemodynamic stability, recovery metrics (QoR-15), and adverse events were systematically evaluated. Statistical analyses adhered to intention-to-treat principles.
resultsThe AUC0.5−24 of VASpain curves of Group PSIP was lower (P = 0.016). The VASpain of Group PSIP were lower at 0.5 h, 2 h, 6 h, 12 h, and 24 h after the extubation (P < 0.001, 0.005, < 0.001, 0.020, 0.029). There was a decrease in VASpain in Group PSIP after blocking (P < 0.001). Patients in Group PSIP required a lesser amount of analgesics within the initial twenty-four hours following surgery (P = 0.026). Group C had a significantly earlier use of analgesics (P < 0.001). At the time of skin incision, fracture reduction, suture and after extubation, Group PSIP had a lower MAP (P = 0.002, < 0.001, 0.003, 0.001) and AUC of MAP curves (P = 0.039). The Group PSIP exhibited lower Ricker scores in PACU, along with shorter observation times as well (P = 0.005, 0.046). The severity of PONV within 24 h post-surgery in the Group PSIP was also lower (P = 0.013). Moreover, at the 24 h post-surgery, the QoR-15 score was higher in Group PSIP (P = 0.025).
conclusionsThe PSIP block demonstrated efficacy in managing postoperative pain in patients with MRFs, mitigating intraoperative hemodynamic fluctuations and agitation during resuscitation, and enhancing short-term recovery outcomes following surgery.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.